E
ChitogenX Inc.
CHGX
CNSX
E
Sell
5/1/2023Downgrade
ChitogenX Inc. (CHGX) was downgraded to E+ from D- on 5/1/2023 due to a decline in the total return index, volatility index and growth index.
ChitogenX Inc. (CHGX) was downgraded to E+ from D- on 5/1/2023 due to a decline in the total return index, volatility index and growth index.
D
Sell
4/14/2023Upgraded
ChitogenX Inc. (CHGX) was upgraded to D- from E+ on 4/14/2023 due to an increase in the volatility index.
ChitogenX Inc. (CHGX) was upgraded to D- from E+ on 4/14/2023 due to an increase in the volatility index.
E
Sell
3/29/2023Downgrade
ChitogenX Inc. (CHGX) was downgraded to E+ from D- on 3/29/2023 due to a decline in the volatility index.
ChitogenX Inc. (CHGX) was downgraded to E+ from D- on 3/29/2023 due to a decline in the volatility index.
D
Sell
3/14/2023Downgrade
ChitogenX Inc. (CHGX) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index.
ChitogenX Inc. (CHGX) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
ChitogenX Inc. (CHGX) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
ChitogenX Inc. (CHGX) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
D
Sell
2/8/2023Downgrade
ChitogenX Inc. (CHGX) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the solvency index, growth index and valuation index. The quick ratio declined from 0.22 to 0.06, earnings per share declined from -$0.0208 to -$0.0273, and debt to equity increased from -0.97 to -0.8.
ChitogenX Inc. (CHGX) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the solvency index, growth index and valuation index. The quick ratio declined from 0.22 to 0.06, earnings per share declined from -$0.0208 to -$0.0273, and debt to equity increased from -0.97 to -0.8.
D
Sell
7/27/2022Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 7/27/2022 due to a large increase in the growth index and volatility index. Operating cash flow increased 26.22% from -$771.6 to -$569.3, and earnings per share increased from -$0.0193 to -$0.017.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 7/27/2022 due to a large increase in the growth index and volatility index. Operating cash flow increased 26.22% from -$771.6 to -$569.3, and earnings per share increased from -$0.0193 to -$0.017.
D
Sell
5/5/2022Upgraded
ChitogenX Inc. (CHGX) was upgraded to D- from E+ on 05/05/2022.
ChitogenX Inc. (CHGX) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index and total return index.
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index and total return index.
D
Sell
4/18/2022Downgrade
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D- from D on 4/18/2022 due to a large decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0211 to -$0.0439, and EBIT declined 69.44% from -$465.3 to -$788.4.
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D- from D on 4/18/2022 due to a large decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0211 to -$0.0439, and EBIT declined 69.44% from -$465.3 to -$788.4.
D
Sell
11/23/2021Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 11/23/2021 due to an increase in the volatility index.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 11/23/2021 due to an increase in the volatility index.
D
Sell
11/8/2021Downgrade
ChitogenX Inc. (CHGX) was downgraded to D- from D on 11/08/2021.
ChitogenX Inc. (CHGX) was downgraded to D- from D on 11/08/2021.
D
Sell
7/30/2020Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 7/30/2020 due to an increase in the total return index, volatility index and growth index.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 7/30/2020 due to an increase in the total return index, volatility index and growth index.
D
Sell
7/1/2020Downgrade
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D- from D on 7/1/2020 due to a large decline in the solvency index and growth index. EBIT declined 143.66% from -$265.9 to -$647.9, earnings per share declined from -$0.0146 to -$0.0291, and operating cash flow declined 82.47% from -$183.1 to -$334.1.
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D- from D on 7/1/2020 due to a large decline in the solvency index and growth index. EBIT declined 143.66% from -$265.9 to -$647.9, earnings per share declined from -$0.0146 to -$0.0291, and operating cash flow declined 82.47% from -$183.1 to -$334.1.
D
Sell
5/18/2020Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 5/18/2020 due to an increase in the total return index and volatility index.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 5/18/2020 due to an increase in the total return index and volatility index.
D
Sell
5/1/2020Downgrade
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 125.45% from -$232.6 to -$524.4, total capital declined 42.17% from -$233.6 to -$332.1, and EBIT declined 33.69% from -$360.6 to -$482.1.
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 125.45% from -$232.6 to -$524.4, total capital declined 42.17% from -$233.6 to -$332.1, and EBIT declined 33.69% from -$360.6 to -$482.1.
D
Sell
12/17/2019Downgrade
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D from D+ on 12/17/2019 due to a decline in the total return index.
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D from D+ on 12/17/2019 due to a decline in the total return index.
D
Sell
11/29/2019Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D+ from D on 11/29/2019 due to an increase in the total return index.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D+ from D on 11/29/2019 due to an increase in the total return index.
D
Sell
11/13/2019Downgrade
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D from D+ on 11/13/2019 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.2 to 0.13, and debt to equity increased from -0.93 to -0.8.
Ortho Regenerative Technologies Inc. (ORTH) was downgraded to D from D+ on 11/13/2019 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.2 to 0.13, and debt to equity increased from -0.93 to -0.8.
D
Sell
7/5/2019Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D+ from D on 7/5/2019 due to a significant increase in the efficiency index, volatility index and total return index. Net income increased 13.9% from -$514.5 to -$443.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D+ from D on 7/5/2019 due to a significant increase in the efficiency index, volatility index and total return index. Net income increased 13.9% from -$514.5 to -$443.
D
Sell
5/31/2019Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 5/31/2019 due to a major increase in the growth index, solvency index and valuation index. Debt to equity declined from 6.51 to -1.94, operating cash flow increased 50.36% from -$290.7 to -$144.3, and earnings per share increased from -$0.0242 to -$0.0169.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D from D- on 5/31/2019 due to a major increase in the growth index, solvency index and valuation index. Debt to equity declined from 6.51 to -1.94, operating cash flow increased 50.36% from -$290.7 to -$144.3, and earnings per share increased from -$0.0242 to -$0.0169.
D
Sell
4/15/2019Upgraded
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D- from E+ on 4/15/2019 due to an increase in the total return index and volatility index.
Ortho Regenerative Technologies Inc. (ORTH) was upgraded to D- from E+ on 4/15/2019 due to an increase in the total return index and volatility index.
E
Sell
4/8/2019None
ChitogenX Inc. (CHGX) was downgraded to E+ from U on 04/08/2019.
ChitogenX Inc. (CHGX) was downgraded to E+ from U on 04/08/2019.
